New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review

Author:

Power Niamh1,Archambault Léonie12ORCID,Perreault Michel13ORCID

Affiliation:

1. Douglas Research Centre, Montréal, QC, Canada

2. Sherbrooke University, Sherbrooke, QC, Canada

3. Department of Psychiatry, McGill University, Montréal, QC, Canada

Abstract

Changes to the landscape of opioid use have occurred throughout the past two decades. Opioid agonist treatment (OAT) plays an important role in reducing opioid-related harms. Yet, people with opioid use disorder (PWOUD) face issues with access and retention. This scoping review sought to provide an up-to-date synthesis on barriers and facilitators to OAT. Ninety-three studies were included. Major barriers included cost, waiting lists, and negative public attitudes toward treatment. Prominent facilitators included OAT education and flexible treatment conditions such as telehealth-delivered OAT. In prison settings, limited support with treatment referral was a barrier. Fear of judgement was a challenge for pregnant people. There was a lack of information on barriers and facilitators specific to PWOUD dealing with chronic pain or mental health comorbidities. Results highlight new challenges in reaching an increasingly heterogeneous PWOUD population. Findings underline the potential for recent advancements in treatment modalities to promote access and retention.

Funder

Ministère de la Santé et des Services sociaux

Institut Universitaire sur les Dépendances

Health Canada

Publisher

SAGE Publications

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3